ELAN - iShares U.S. Pharmaceuticals ETF: Favorable Long-Term Growth Outlook Should Drive Future Price Appreciation
ETF Overview
iShares U.S. Pharmaceuticals ETF (IHE) owns a portfolio of large-cap pharmaceutical stocks. The ETF tracks the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. Stocks in IHE's portfolio are stocks with competitive advantages over their smaller peers. In addition, these stocks will benefit from rising pharmaceuticals demand in the world. IHE's stocks are fairly valued against their historical averages. Given the favorable long-term growth outlook, we believe the fund is a good choice for investors with a long-term investment horizon.
Data by YCharts
ETF Analysis
Stocks in IHE's portfolio